Pediatric Praziquantel program awarded additional grant from the Global Health Innovative Technology (GHIT) Fund
05 MAY 2017
The GHIT Fund recently announced that it will continue to support the Pediatric Praziquantel program led by our company and currently in Phase II.
After being awarded grants in 2014 and 2015 for the phase I and II of the program, the latest grant of US$4.7m will allow the Pediatric PZQ Consortium to perform Phase III and prepare for registration. Our company and the Consortium is excited to continue its partnership with the GHIT Fund, which has been an important contributor in moving ahead the program.